Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

The centre is set to provide a patient-centric approach to treatment, backed by a multidisciplinary team of specialists.

Maharashtra Chief Minister Devendra Fadnavis highlighted Prime Minister Narendra Modi`s efforts to free the country from the ...

Editas Medicine reports successful gene editing levels in stem cells, supporting potential treatment for sickle cell disease and beta thalassemia. Editas Medicine announced promising new data on ...

Burjeel Holdings has launched a Thalassemia and Sickle Cell Centre at Burjeel Medical City (BMC) in Abu Dhabi, marking a significant step towards ...

In a major breakthrough, a patient has been treated with a personalized CRISPR therapeutic that aims to cure their rare genetic disease... | Genetics And Genomics ...

Family overjoyed correction to DNA defect that causes metabolic disorder has given KJ Muldoon a new lease of life ...

The newly inaugurated Thalassemia and Sickle Cell Center by Burjeel Holdings' state-of-the-art facility will provide ...

CRISPR Therapeutics benefits from Casgevy’s approval and a deep pipeline, despite early rollout hurdles and cost challenges.

Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and pyruvate kinase (PK) activation pioneering therapies for rare diseases, today announced that new data on the company’s ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, ...

The presentations will showcase clinical and preclinical findings related to rare blood disorders, including sickle cell disease, thalassemia, and myelodysplastic syndromes. Highlights include ...